Results 271 to 280 of about 451,014 (336)

A return on investment analysis for the 2017 increase in alcohol excise taxation in Lithuania

Addiction, EarlyView.
Abstract Aims To conduct a return on investment analysis of Lithuania's 2017 increase in alcohol excise taxation of 112% for beer, 111% for wine, and 23% for ethyl alcohol (spirits), resulting in a marked decrease in alcohol affordability. Methods Economic analyses based on costs of the increased taxation and economic benefits derived from a societal ...
Jürgen Rehm, Pol Rovira, Ahmed S. Hassan, Claire de Oliveira, Shannon Lange, Mark J. Thompson, Ilona Tamutienė, Vaida Liutkutė‐Gumarov, Lukas Galkus, Mindaugas Štelemėkas   +9 more
wiley   +1 more source

A step-up approach or open necrosectomy for necrotizing pancreatitis.

New England Journal of Medicine, 2010
H. V. van Santvoort, M. Besselink, O. Bakker, H. Hofker, M. Boermeester, C. Dejong, H. van Goor, A. Schaapherder, C. V. van Eijck, T. Bollen, Bert van Ramshorst, V. Nieuwenhuijs, R. Timmer, J. Lameris, P. M. Kruyt, E. Manusama, Erwin van der Harst, G. P. van der Schelling, T. Karsten, E. J. Hesselink, Cornelis J. van Laarhoven, C. Rosman, K. Bosscha, Ralph J. de Wit, A. Houdijk, Maarten S. van Leeuwen, E. Buskens, H. Gooszen   +27 more
semanticscholar   +1 more source

Trajectories of hospital‐presenting alcohol‐related disorders between early and late adulthood: Exploring the role of mortality in a prospective study of a 1953 cohort

Addiction, EarlyView.
Abstract Background and aims Alcohol‐related disorders (ARDs) are associated with severe attributable harms that evolve throughout the life course, comprising distinct trajectories. Yet, how mortality affects the identification, shape and number of trajectory groups remains poorly understood.
Lauren Bishop, Lars Brännström, Ylva B. Almquist   +2 more
wiley   +1 more source

The Hideous Side of Acute Pancreatitis: A Case of Pancreatitis-Induced Atypical Hemolytic Uremic Syndrome. [PDF]

Cureus
Al-Ali H, Elmogy A, Arsh H, Rhee H.
europepmc   +1 more source

Real‐World Survival Outcomes of Patients With High PD‐L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus Immunotherapy

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Are two drugs better than one in advanced NSCLC? ABSTRACT Background Randomized studies have demonstrated superior overall survival (OS) of pembrolizumab (pembro), both alone and in combination with chemotherapy (chemo) over chemo alone in patients with programmed cell death ligand‐1 (PD‐L1) ≥ 50% advanced non–small cell lung cancer (NSCLC).
Junipearl Cheng, Charlotte McKay, Victoria Bray, Po Yee Yip, Annette Tognela, Peey Sei Kok   +5 more
wiley   +1 more source

Acute Necrotizing Pancreatitis-Advances and Challenges in Management for Optimal Clinical Outcomes. [PDF]

Medicina (Kaunas)
Dumitrascu I, Zarnescu NO, Zarnescu EC, Pahomeanu MR, Constantinescu A, Minca DG, Costea RV.   +6 more
europepmc   +1 more source

Autoimmunity to Pancreatic juice in Crohn´s Disease [PDF]

, 1987
Finkbeiner, H., Lehnert, Peter, Normann, D., Otte, M., Stöcker, K., Stöcker, W., Ulrich, S.   +6 more
core